Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y009782 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
she starting having swollen lymph nodes, sore throat, headache and a rash on her belly. Caller advised she took her daughter to the HCP on 04/25/2025 and she had EpsteinBarr and tested positive for mono.; This spontaneous report was received from a consumer and refers to a 11-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-Apr-2025, the patient (her daughter) received Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) 0.5 mL injection in the arm (lot #Y009782, expiration date: 23-May-2026) as prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported). Operator of device was reported as lay user/patient. On 24-Apr-2025 and 25-Apr-2025, the patient started having swollen lymph nodes, sore throat, headache and a rash on her belly. She took her daughter to the HCP on 25-Apr-2025 and she had Epstein-Barr and tested positive for "mono" (Epstein-Barr virus test positive). The reporter advised her daughter's lymph nodes had went down but they were still enlarged and she was tired and fatigue. At the reporting time, the patient had not recovered from the event. The action taken was not applicable. The causal relationship between the event, Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) and reconstituted suspect sterile diluent was not reported.
Test Date: 20250425; Test Name: EpsteinBarr; Result Unstructured Data: positive for "mono"